• Dis-Chem Healthy revenues

  A so-so set of interims from Dis-Chem for the six months through August, with Group revenue +9.6% to R19.6bn YoY, with retail revenue growth +7.1%. Dispensary sales were a big earner, accounting for 37.3% of the Retail haul. No mention of internal in... More »

  • Trade Intelligence Analytics 04/11/24

• ---

• Dis-Chem Fong Pong

  A cautionary tale this week from Dis-Chem which has removed from its shelves the Sol de Janeiro line of products that is majority-owned by posh French fragrance brand L’Occitane. The range was launched by Dis-Chem amid much fanfare, having found popu... More »

  • Supermarket 03/10/24

• ---

• Dis-Chem A shed load of cash

  One of the interesting features about the rise of Dis-Chem has been its vertical integration of the pharmaceutical value chain, from financial services, to medical services, to wholesale, to actual product. And part of its growth strategy, following ... More »

  • Business Day 09/09/24

• ---

• Dis-Chem Vertically challenged

  Vertical integration, according to the Worthies at Oxford, is “the combination in one firm of two or more stages of production normally operated by separate firms.” It’s the Holy Grail for businesses with the ambition of owning everything in sight, a... More »

  • Daily Investors 16/07/24

• ---

• Dis-Chem File under things that make you go ‘hmmm’

  Follow closely, this one’s a bit tricky. A week or so ago, we reported with some admiration that Dis-Chem had acquired a 50% stake in US-based start-up insurance provider, OneSpark, in its efforts to vertically integrate itself into the medical value... More »

  • Financial Mail 13/06/24

• ---

More articles